← All trials
NCT01769911
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2015
- Primary completion
- Feb 1, 2019
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of WashingtonLead sponsor
- National Cancer Institute (NCI)Collaborator
- University of WashingtonOverall official - principal investigator
Drugs studied
Indications studied
- Burkitt Lymphoma
- Hodgkin Disease
- Leukemia, Hairy Cell
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Non-Hodgkin
- Lymphomatoid Granulomatosis
- Waldenstrom Macroglobulinemia
- Sezary Syndrome
- Testicular Neoplasms
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia-Lymphoma, Adult T-Cell
- HIV Infections
- Lymphoma, T-Cell
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, T-Cell, Peripheral
- Lymphoma, AIDS-Related
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Mantle-Cell
- Leukemia, Large Granular Lymphocytic
- Intraocular Lymphoma
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.